Realizing that together we are better, West Cancer Center is dedicated to providing patients - and medical professionals - with the information, training and resources necessary to ensure complete transparency in the treatment of cancer. 

As experts in their respective fields, West Cancer Center physicians and researchers represent a unique ability to consistently reconcile clinical care and scientific innovation – a dual approach that provides patients with access to cutting-edge treatment and care. Our physicians and researchers collaborate with their peers and colleagues, sharing their findings through numerous scientific abstracts, publications, and presentations throughout the year.

Recent Publications and Presentations

Daruka Mahadevan, MD, PhD: Phase II Intergroup Trial of Alisertib in Relapsed and Refractory Peripheral T-Cell Lymphoma and Transformed Mycosis Fungoides: SWOG 1108.

Lee S. Schwartzberg, MD, FACP: Safety and efficacy of rolapitant for prevention of chemotherapy-induced nausea and vomiting after administration of moderately emetogenic chemotherapy or anthracycline and cyclophosphamide regimens in patients with cancer: a randomised, active-controlled, double-blind, phase 3 trial.

Benny Weksler, MD, and Jennifer Sullivan, MD: Racial and Ethnic Differences in Lung Cancer Surgical Stage: An STS Database Study.

Daruka Mahadevan, MD, PhD: Novel receptor tyrosine kinase targeted combination therapies for imatinib-resistant gastrointestinal stromal tumors (GIST)

Noam A. VanderWalde, MD: Effectiveness of Chemoradiation for Head and Neck Cancer in an Older Patient Population

Meiyun Fan, PhD, and Larry Pfeffer, PhD: Systematic analysis of metastasis-associated genes identifies miR- 17-5p as a metastatic suppressor of basal-like breast cancer

Lee S. Schwartzberg, MD: PEAK: a randomized, multicenter phase II study of panitumumab plus modified fluorouracil, leucovorin, and oxaliplatin (mFOLFOX6) or bevacizumab plus mFOLFOX6 in patients with previously untreated, unresectable, wild-type KRAS exon 2 metastatic colorectal cancer

Ramesh Narayana, PhD: Selective Androgen Receptor Modulators (SARMs) Negatively Regulate Triple-Negative Breast Cancer Growth and Epithelial: Mesenchymal Stem Cell Signaling